<DOC>
	<DOCNO>NCT03069846</DOCNO>
	<brief_summary>The primary objective collect emission spectrum normal tissue , pigment normal lesion , benign lesion , SCC , BCC melanoma construct database validate classify algorithm .</brief_summary>
	<brief_title>Diagnosing Melanoma , Squamous Cell Carcinoma Basal Cell Carcinoma Using Spectra-Scope</brief_title>
	<detailed_description>The Speclipse Spectra-Scope consist light collection module spectral analysis module . The light collection module attach handpiece short pulse ( nanosecond ) Nd : YAG ( neodymium-doped yttrium aluminium garnet ) commercial cosmetic laser , analysis module place laser . When Nd : YAG laser irradiate onto skin lesion , laser ablates trace amount tissue , produce micro plasma . The emitted light micro plasma analyse spectrally determine elemental molecular information tissue real time . No calibration Spectra-Scope require . Before skin irradiate laser , select age , sex position target skin lesion put patient number day software panel laptop connect device . Prior sampling , skin site must wipe ethanol allow air dry . When laser irradiate , emission spectra tissue automatically generate spectrometer inside device simultaneously display monitor , store laptop . The spectral data store laptop wirelessly accessible use Google drive . An algorithm determines whether skin normal , pigmented normal , benign , squamous cell carcinoma ( SCC ) , basal cell carcinoma ( BCC ) melanoma base spectral 'signature ' . These algorithm determine clinical ex-vivo in-vivo study perform Korea . The purpose study collect tissue emission spectra Australian patient refine algorithm , confirm appropriate spectra 'normal ' , 'benign ' , 'melanoma ' , 'SCC ' , 'BCC ' . Each potential skin cancer site , previously identify require biopsy , assess use five laser shot last approximately 10 millisecond per shot measurement . The laser shot make schedule biopsy . Some potential skin cancer sit label cancer ( 'melanoma ' , 'SCC ' 'BCC ' ) biopsy result , potential skin cancer site label 'benign ' ( control group 1 ) biopsy result .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<criteria>1 . Be age 18 year ; 2 . Have least one suspicious lesion : 1 . Is require biopsied assessment skin cancer ( assess least one dermatologist ) ; 2 . Has diameter 2 mm less 22 mm ; 3 . Is accessible SpectraScope device ; 3 . Provide write informed consent . 1 . Have know allergy ethanol ; 2 . Have lesion : 1 . Has previously biopsied , excise traumatise ; 2 . Is intact ; 3 . Is within 1 cm eye ; 4 . Is mucosal surface ( lip , genitals ) ; 5 . Is palmar hand ; 6 . Is palmar foot ; 7 . Is nails ; 8 . Is locate area visible scarring ; 9 . Contains foreign matter ( tattoo , splinter , marker ) 3 . Have active infection ; 4 . Have open lesion sample ; 5 . Have autoimmune disease lupus scleroderma vitiligo .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>skin cancer</keyword>
	<keyword>laser spectroscopy</keyword>
	<keyword>non-invasive diagnostics</keyword>
</DOC>